LEADER 03808nam  22006255  450 
001 9910739487003321
005 20200705003257.0
010   $a1-4614-7351-9
024 7 $a10.1007/978-1-4614-7351-0
035   $a(CKB)3710000000024276
035   $a(EBL)1538540
035   $a(SSID)ssj0001049048
035   $a(PQKBManifestationID)11550205
035   $a(PQKBTitleCode)TC0001049048
035   $a(PQKBWorkID)11018905
035   $a(PQKB)10355376
035   $a(DE-He213)978-1-4614-7351-0
035   $a(MiAaPQ)EBC1538540
035   $a(PPN)176097988
035   $a(EXLCZ)993710000000024276
100   $a20131011d2013      u|             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aSmoking and Lung Inflammation$b[electronic resource] $eBasic, Pre-Clinical and Clinical Research Advances /$fedited by Thomas J. Rogers, Gerard J. Criner, William D. Cornwell
205   $a1st ed. 2013.
210  1$aNew York, NY :$cSpringer New York :$cImprint: Springer,$d2013.
215   $a1 online resource (217 p.)
300   $aDescription based upon print version of record.
311   $a1-4614-7350-0 
320   $aIncludes bibliographical references.
327   $aIntroduction -- Immunopathology of COPD -- Monocyte Populations Which Participate in Chronic Lung Inflammation -- Neutrophils Inflammation in COPD -- Role of Epithelial Cells in Chronic Inflammatory Lung Disease -- The Relationship Between Oxidative Stress Responses and Lung Inflammation with Cigarette Smoking -- Autoimmune Mechanisms Contributing to Chronic Obstructive Pulmonary Disease -- Chronic Obstructive Pulmonary Disease (COPD): Local and Systemic Disease -- Infectious Mechanisms Regulating Susceptibility to Acute Exacerbations of COPD -- COPD: Biomarkers and Phenotypes -- Anti-inflammatory Therapeutics in COPD: Past, Present and Future.
330   $aSmoking and Lung Inflammation is the first book directly related to chronic lung inflammation of its kind in several respects. First, the it focuses on both basic and clinical research on COPD, and the inflammatory mechanisms that function in these diseases. Second, it is unique with respect to scope of the discussion of the unusual characteristics of the immune response which occurs in these patients. Third, it includes knowledge being gained from translational research conducted through clinical trials at several Medical Schools in the United States. Not only is this research providing information about novel drugs and therapies, but it is also advancing our understanding of the genetics of these diseases. This work will illuminate the molecular basis for these diseases, and hopefully will permit us to individualize the therapies for these diseases.
606   $aImmunology
606   $aRespiratory organs?Diseases
606   $aPathology
606   $aImmunology$3https://scigraph.springernature.com/ontologies/product-market-codes/B14000
606   $aPneumology/Respiratory System$3https://scigraph.springernature.com/ontologies/product-market-codes/H33134
606   $aPathology$3https://scigraph.springernature.com/ontologies/product-market-codes/H4800X
615  0$aImmunology.
615  0$aRespiratory organs?Diseases.
615  0$aPathology.
615 14$aImmunology.
615 24$aPneumology/Respiratory System.
615 24$aPathology.
676   $a616.200471
702   $aRogers$b Thomas J$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aCriner$b Gerard J$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aCornwell$b William D$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910739487003321
996   $aSmoking and Lung Inflammation$93554610
997   $aUNINA